Autism is a developmental disorder characterized by impairments in social interaction and communication associated with repetitive patterns of interest or behavior. Autism is highly influenced by genetic factors. Genome-wide linkage and candidate gene association approaches have been used to try and identify autism genes. A few loci have repeatedly been reported linked to autism. Several groups reported evidence for linkage to a region on chromosome 16p. We have applied a direct physical identity-by-descent (IBD) mapping approach to perform a high-density (0.85 megabases) genome-wide linkage scan in 116 families from the AGRE collection. Our results confirm linkage to a region on chromosome 16p with autism. High-resolution single-nucleotide polymorphism (SNP) genotyping and analysis of this region show that haplotypes in the protein kinase c-beta gene are strongly associated with autism. An independent replication of the association in a second set of 167 trio families with autism confirmed our initial findings. Overall, our data provide evidence that the PRKCB1 gene on chromosome 16p may be involved in the etiology of autism. Molecular Psychiatry (2005) 10, 950-960.
Autism is a developmental disorder characterized by impairments in social interaction and communication associated with repetitive patterns of interest or behavior. 1 Autism in the strict sense is defined by these three abnormalities and marks a severe clinical diagnosis within a spectrum of pervasive developmental disorders including Rett syndrome, Asperger syndrome and other non-specified developmental disorders.
Depending on the clinical criteria and the geographical location, estimations of the prevalence of autism vary between 0.05 and 0.6%. 2, 3 The sharpest rise in prevalence in recent history has been reported from the state of California where the prevalence was reported to have increased by almost 300% between 1987 and 1994. 4 Autism shows a well-established gender distortion with about four times as many male subjects than female subjects being affected. 5 Monozygotic and dizygotic twin studies have shown that autism has a significant genetic component with monozygotic twin concordance rates as high as 91% if broad diagnostic criteria are applied. Dizygotic twin concordance rates are within the range for the sibling recurrence rate of 4.5-5%. [6] [7] [8] [9] Autism does not follow a simple Mendelian inheritance pattern and this is thought to be due to the involvement of multiple genes. 10 Candidate gene and genome-wide approaches have been used to identify loci and genes for autism. Candidate gene approaches have focused on genes responsible for syndromes that in some cases include symptoms of autism such as Rett syndrome or Fragile X for which the causative genes are known. [11] [12] [13] [14] [15] [16] Other strategies include genes that were found or known to be involved in brain development and function. 17, 18 Several genome-wide linkage screens using microsatellites have been performed to identify autism susceptibility loci. [19] [20] [21] [22] [23] [24] [25] [26] [27] If one arbitrarily only considers LOD scores above 1.5, twelve genomic regions have been identified to date linked to varying definitions of autism. Four regions in particular have been replicated in several studies at this threshold, loci on chromosomes 2q, 7q, 16p and 17q. 19, 20, 25, 28, 29 Recently, Ramoz et al 30 reported the association of the SLC25A12 gene with autism within the region of linkage on chromosome 2q24-q33 that they had identified earlier. In their linkage study they had been able to significantly increase the evidence for linkage by using a narrower definition of the autistic phenotype. 24, 29 The use of narrow phenotypes to reduce genetic heterogeneity has been proposed to increase the power to detect linkage. 31 The reasoning behind this is that people with a more severe form of disease have a stronger genetic component and hence the identification of such genes will be facilitated.
In this study we followed this rationale, using a phenotype with strict autism diagnostic criteria, as defined by the Autism Diagnostic Interview Revised (ADI-R). 32 Speech delay beyond 36 months of age, for which increased familial segregation has been shown, 33 was used as a further inclusion criteria to narrow the phenotype. We performed a genome-wide linkage scan in 116 families obtained from the Autism Genetic Resource Exchange (AGRE) DNA repository (www.agre.org). To further increase the power to detect linkage, we used a direct, physical identity-by-descent (IBD) mapping technology to perform a highly informative genome-wide linkage scan at a high density of less than 1 Mb (megabase). We identified seven loci with significant evidence for linkage, several of which had already been reported in earlier microsatellite-based studies. [20] [21] [22] 25, 26 The linkage intervals in our study are generally significantly narrower than those identified previously with an average spread of 1.7 Mb. In our ongoing effort to identify the autism susceptibility genes within our linkage regions, we here report results for the region on chromosome 16p. Using a regional high-density single-nucleotide polymorphism (SNP) fine mapping approach, we identified a significant association between a haplotype in the protein kinase c-beta gene on chromosome 16p11.2 and autism.
Materials and methods

Subjects
All families were selected from the Autism Genetic Research Exchange program. All individuals within this program have been evaluated according to the autism diagnostic interview revised (ADI-R). For the initial study, families were included if both affected sibs in the family showed all three developmental disabilities characteristic for autism (impairments in social interaction and communication associated with repetitive patterns of interest or behavior) and if both were concordant for delayed onset of speech beyond 36 months of age. A total of 116 families corresponding to these criteria were selected. Within these selected families, 48% of autistic individuals were also evaluated by Autism Diagnostic Observation Schedule (ADOS) 34 and 94% of these were considered autistic by this evaluation (the remaining being scored as spectrum disorder).
For independent confirmation of association results, a second set of 167 trio families was selected from the AGRE family collection according to the same inclusion criteria. ADOS evaluation was performed in 65% of the affected individuals in this set.
Direct IBD selection
In simplified form, the method of direct IBD selection consists of mixing digested genomic DNA from two related, affected individuals within a family and rehybridization of the mixed fragments. Specific tagging of each DNA allows the elimination of rehybridization products stemming from only one individual (carrying only a single tag). Mismatch repair enzymes are then used to eliminate all hybrid fragments bearing sequence differences, which are therefore non-IBD. The resulting hybrid fraction is thereby highly enriched for IBD DNA and these regions can be identified by hybridizing this solution against a DNA array with a representation of the genome on its surface.
Genomic DNA was digested with XbaI or with PstI and purified and concentrated with Multiscreen Manu-30 (Milipore) ultrafiltration. The purified, digested DNA was tagged by ligation of adaptors or methylation of one of the DNA samples with Dam methylase as described by Brooks et al 35 and Nelson et al, 36 respectively. In total, 1.5 mg of each of the samples were combined, denatured by incubation in 0.15 M NaOH at RT for 10 min, neutralized by addition of Hybridization buffer (HyF buffer: NaP (100 mM), pH 6.9, EDTA (0.1 mM), NaClO 4 (1.15 M), deionised formamide and NaAc (35 mM) and phenol (10%). The emulsion was shaken for 18 h. The hybridization products were purified by ultrafiltration. Unpaired single-stranded DNA was eliminated by adding benzoyl-naphthoyl-DEAE cellulose (BNDC, Sigma) in 1 Â TLE buffer (Tris-HCl, pH 8, 10 mM, LiCl 800 mM and EDTA 1 mM). The resulting hybrid duplexes were purified by ultrafiltration. An aliquot of the resulting hybrid DNA was kept for subsequent labeling and hybridization to microarrays.
The hybrid DNA was incubated with a formulation of Escherichia coli MutS (0.2 mM), MutL (0.15 mM) and MutH (0.025 mM), in enzyme buffer (Na-Hepes (30 mM) pH 7.4, EDTA (0.1 mM), NaOAc (220 mM), 80% glycerol, 20% Tween 20 and mercapto-etahnol) at 371C for 15 min and heated for 10 min at 651C. Then, exonuclease III was added, incubated for 30 min at 371C, 1 Â TLE added and treated with BNDC to isolate IBD-enriched duplex DNA free of singlestranded digestion products. Methyl-tagged DNA were incubated with MboI and DpnI for 30 min at 371C and 10 min at 651C preceded the exoIII digestion. IBD-enriched DNA was amplified using TempliPhi (Amersham) as recommended by the manufacturers, with minor modifications.
In total, 1 mg of IDB-enriched and amplified DNA was labeled with Cyanine-5 or 1 mg of amplified hybrid DNA with Cyanine-3 by incubation for 16-18 h at 371C with Klenow (exo-) DNA polymerase (NE Biolabs) in 30 ml reactions containing 125 mM random octamers, 120 mM dATP, dGTP, TTP, 60 mM dCTP and either 50 mM Cy5-dCTP or 50 mM Cy3-dCTP. The labeled DNA was purified by spun gel filtration through Sephadex G50 (APB Biotech) in HV45 microplates (Millipore). Slides were blocked by incubation in 10% BSA, 0.01% SDS at 371C for 30 min and hybridized in a water bath at 421C for 48 h. After hybridization, slides were rinsed in 2 Â SSC, soaked in SWB at 451C for 10 min, and then slides were briefly rinsed in a series of baths: 0.2 Â SSC, filtered 0.1 Â SSC and 70% isopropanol.
Microarray analysis
Microarrays were scanned using an Agilent scanner and fluorescent intensities were corrected by subtraction of local background using GenePix s Pro 5.1. Spots with fluorescent saturation signals (450 000) or signals less than two times the mean of the backgrounds from all autosomal clones were excluded. A ratio value of IBD-enriched DNA vs hybrid DNA was determined based on the four spot replicates for each clone. Clones with less than three morphologically acceptable replicates or with excessive variance of replicate ratios (Var(replicate)ÀMean(Var(replicates)) 42 Â Var(Var(replicates))) were eliminated. Median ratios of the replicates for each clone were computed and data were normalized, by dividing the ratio of each clone by the mean ratio of all autosomal clones. Clone ratios were standardized using 150 full sib-pair controls by subtracting the mean of the control clone ratios and dividing by the variance of the control clone ratios.
IBD determination
Moving averages (MA) were determined from the normalized ratios for each clone. Briefly, moving averages are used to generate a new sequence of values by successively computing the averages of the values lying within a window of a given length (in this case a fixed number of clones). We considered the windows centered on each clone (ie windows included values from index iÀm to i þ m). Averages were weighted so that the nearest neighboring clone of clone i contributed more to the average than the more distant ones. For this purpose, we used a function with a Gaussian shape. The weight d ij can then be expressed as a function of the distance between clone i and clone j in megabases.
Thus, moving averages were calculated as follows: m was set to 3, corresponding to a moving window of seven adjacent clones. Under the null hypothesis (H 0 ) of no linkage, an average of 75% (the sum of all expected IBD values ¼ 50% (IBD 1) þ 25% (IBD 2)) of the clones are expected to be IBD for sib pairs. A threshold ratio T was determined such that 75% of the MA ratios from all clones and all sib-pair controls were greater than T. The IBD status of clones with MA ratios greater than T were set to 1 and those with MA ratios less than T were set to 0, respectively.
SNP selection and genotyping
The positive region on chromosome 16p13.1 to 11.2 was annotated according to the 34th version of the NCBI database (http://www.ncbi.nlm.nih.gov/ genome/guide/human/). SNPs were selected from the Celera database using the SNP-Browser tool (www.appliedbiosystems.com) and the HapMap database (http://www.hapmap.org/). An internally developed algorithm was used to create an approximate homogeneous SNP map of 20 kilobases (kb) across the 4.5 Mb linkage region. SNPs were included based on position, spacing and heterozygosity (410% for the minor allele frequency). A total of 214 SNPs were selected for genotyping.
SNPs were genotyped using an oligo-ligation assay (SNPlex, Applied Biosystems, Foster City) following the manufacturer's guidelines. Briefly, the method consists of designing three specific primers per SNP with two primers carrying the SNP-base-specific 3 0 -end and one common primer that starts 5 0 with the next base in the target sequence. The two, allelespecific primers carry unique ZIP codes that determine each allele. Primers are annealed to the target sequence according to the manufacturer's recommendations and a ligation reaction will join the allele-specific primer with the common primer if the allele-specific 3 0 -base is present. A short fluorescent dye-labeled probe, homologous to the ZIP code sequence, is then hybridized to the immobilized product. Up to 48 SNPs can thus be multiplexed into one oligo-ligation reaction. Following the manufacturer's recommendations, genomic DNA was heat fragmented. Phosphorylated probes were added, the gDNA denatured at 901C for 3 min and the oligoligation assay performed on a PE 9700 thermal cycler following the manufacturer's protocol with 30 cycles of 901C for 15 s, 601C for 30 s and 511C for 30 s, followed by a denaturation step at 991C for 10 min to recover the ligation products. After washing and subsequent denaturation at 951C for 10 min, the ligation products were amplified by PCR for 30 cycles at 951C for 15 s and an annealing/amplification step at 701C for 60 s using biotynylated primers. Amplification products were recovered in a strepavidin-coated plate and hybridized with the allele-specific ZIPchute probe. Plates were washed and SNPlex sample loading reagent was added to the plates and the allele-specific fluorescent probes were separated on an automated sequencer (ABI 3730, Applied Biosystems, Foster city). Alleles were binned and called using the GeneMapper software (Applied Biosystems, Foster City).
Linkage analysis
Linkage analysis from direct IBD mapping data was performed using a statistical test based on convolution of a binomial as described by Smalley et al.
37.
In the case of affected sib-pairs only, the shared allele number in N pairs under the null hypothesis of no linkage is a binomial and denoted:
ZBBin (N, p 1 þ p 2 ) with p 1 þ p 2 ¼ 0.75 being the expected probability of IBD between the sib-pair. The null hypothesis (H 0 ) is rejected if ZZb. In the context of a whole genome scan, b was chosen so that PRKCB1 gene association with autism A Philippi et al P(ZZb)o2 Â 10 À5 as a threshold for genome-wide significance.
For linkage analysis from SNPs, all SNP data were checked for correct Mendelian transmission using the Unknown program of the LINKAGE package. 38 The Hardy-Weinberg equilibrium was evaluated for each SNP from parental genotype data. A total of 214 SNPs were genotyped as described above. Recombination frequencies were approximated from the physical distances between SNPs. SNP allele frequencies were estimated with the ILINK program of the LINKAGE package by likelihood maximization using all genotyped individuals. Multilocus nonparametric linkage analysis was performed using the GENEHUN-TER 2.1. Model-free allele sharing was assessed via the NPL statistic, based on estimated allele sharing for all affected relative pairs in the data set. This scoring function was asymptotically distributed as the Z statistic. 39 
LD map
Pairwise LD among SNPs was investigated using the Haploview software. 40 . We used the standard color scheme heat-map: white for D 
SNP association analysis
Single SNP and haplotype association tests were carried out using the TDT option of the GENHUNTER package and TDTPHASE and PDTPHASE from the UNPHASED v2.403 package of programs. 41 The TDT test of GENEHUNTER only considers phased haplotypes that can be unambiguously determined from the parental genotype data and calculates the difference between the number of transmissions and nontransmission as a w 2 statistic. The TDTPHASE test includes uncertain, unphased haplotypes. The EM algorithm is used to obtain maximum-likelihood estimates of parental haplotype frequencies under both null and alternative hypothesis. PDTPHASE is an implementation of the pedigree disequilibrium test with unphased haplotypes (EM algorithm) and missing data. We used sum option, which weighs larger families. In both the TDT and PDT tests, rare haplotypes with frequencies o0.05 are grouped. Sliding windows of three SNPs were used to construct haplotypes.
Results
Linkage analyses
We studied 116 sib pairs concordant for autism using strict diagnostic criteria as defined by the ADI-R 32 and speech delay beyond the age of 36 months. A direct IBD mapping method was applied to carry out a genome-wide linkage scan. The IBD-enriched genomic DNA fraction from each sib-pair was hybridized against a BAC-derived DNA chip covering the human genome at a resolution of 0.85 Mb. Seven genomic regions on chromosomes 1, 5, 12, 13, 14, 16 and 17 showed significant increase of IBD sharing among sibpairs (IBD between 0.86 and 0.93) over the expected proportion for no linkage (H 0 ¼ 0.75). Four of the seven loci fall within intervals reported to be linked to autism in earlier studies (chromosomes 5, 13, 16 and 17). [20] [21] [22] 25, 26 The spread of the linkage intervals (defined as a 2log drop in significance to each side of the highest P-value) ranged from 750 kb (chromosome 5q) to 4.5 Mb (chromosome 16p) with an average of Figure 1 Results for a high-resolution (0.85 Mb) direct IBD mapping genome-wide linkage scan in autism. IBD was determined using signal ratios on a BAC clone DNA-based microarray after enzymatic IBD selection. Evidence for linkage was calculated as significant increase in IBD sharing over expected random sharing. In all, 116 AGRE sib-pair families were screened. The figure shows the results for all chromosomes from pter to qter. Vertical lines show the limits for each chromosome. Distances are in megabases (not centiMorgan). A threshold of P ¼ 2.5 Â 10 À5 was used as evidence for linkage.
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PRKCB1 gene association with autism A Philippi et al 1.7 Mb. Genome-wide linkage results are presented in Figure 1 . In our ongoing efforts to identify the genes in the linkage regions, we also concentrated on chromosome 16p, a region that has been shown to be linked to autism in several independent microsatellite genome scans but for which the gene had not yet been identified. 21, 23, 25 The Table 1 .
In order to further narrow the region, we selected 113 single-nucleotide markers covering the entire linkage region at an average marker distance of 39 kb (the complete SNP marker list is available as Supplementary data or on request). SNPs were genotyped and analyzed for correct Mendelian transmission and deviations from the Hardy-Weinberg equilibrium. One SNP (hCV2387989) showed a consistent error for Mendelian transmission within the families and was excluded from further analysis. A total of 10 SNPs showed significant deviation from the Hardy-Weinberg equilibrium and were also excluded from the analysis (data not shown).
To confirm the initial linkage finding and further characterize the interval, a multipoint linkage analysis was performed on the selected SNPs using the NPL function of the Genehunter program. A maximum multipoint NPL of 2.5 was obtained at SNP hCV1089803 at base position 23741121.
Single point SNP association analysis Initially, 113 SNPs were genotyped in 464 individuals from the first set of 116 autistic families. Single point SNP analysis was carried out using two different programs (Genehunter and UNPHASED using both the TDT and PDT functions) to determine association between markers and autism in the linkage region. Several SNPs showed evidence for association at nominally significant P-values (Po0.05) in the singlemarker analysis. One and three of the positive SNPs were localized in distinct genes, the otoancorin (OTOA) and the protein kinase C-beta gene (PRKCB1), respectively. The most significant value for single SNP association was observed for transmission of the T-allele of SNP 128 (hCV2192108, P ¼ 0.0027) within the PRKCB1 gene in the Genehunter analysis. Results were consistent over all analysis programs with comparable significance levels (P ¼ 0.005 for TDTPHASE and P ¼ 0.002 for PDTPHASE, respectively). The three most positive SNPs 128, 136 (hCV11192725) and 140 (hCV946275) are all intragenic for the PRKCB1 gene, which plays a vital role in the regulation of synaptic function, 42 making it a reasonable positional and functional candidate. Another single SNP (SNP 73, hCV789442) located within the OTOA gene also showed a nominal significant Pvalue (P ¼ 0.01). To increase the information content and narrow down the interval of association, the SNP density in the two genes was increased to one SNP Figure 2 Detailed results for linkage analysis on chromosome 16 . The x-axis shows the position of clones and distances in megabases. The y-axis shows P-values for each position. Increased IBD sharing was estimated over the expected value under H 0 ¼ no linkage (for sib-pairs, expected total sharing is the sum of all IBD values, ie 50% (IBD 1) þ 25% (IBD 2) ¼ 0.75). Five clones in the region showed elevated IBD sharing values. The highest P-value was observed for clone FE0DBACA7ZD06v. Figure 4 shows the LD within the PRKCB1 gene in the form of a heat-map. Three major haplotype blocks were observed within the gene situated at the beginning, the middle and the end (from 5 0 to 3 0 ) of the 300 kb of genomic sequence of the gene. Further, we established separate LD maps for the Caucasian and Mexican-American population subsets (Figure 1, Supplementary data) . The block structure of the two subgroups shows clear differences with a marked decrease in LD for the second large haplotype block in the Mexican-American group as compared to the Caucasian subset.
Haplotype analysis
Following the positive single SNP results in the PRKCB1 gene, we used all SNP genotype data in the gene to perform a haplotype analysis with the extended marker set. Haplotypes were defined by three-marker windows moving along the gene in 5 0 À 43 0 direction. Haplotype analyses were carried out using TDTphase and PDTPhase 41 as well as the TDT function of the Genehunter package. Several haplotype windows showed positive global significance values. The most significant P-value was observed for the three-marker haplotype C-G-T including SNPs 139-140-141 (P ¼ 2.96 Â 10
À5
). The Database reference for positive SNPs is shown in Table 2 .
Next, we studied a second independent set of 167 trio families for replication of the association results. The haplotype analysis confirmed the evidence for association within the gene. However, the most significant haplotype observed was shifted in respect to the initial finding. Analysis results are presented in Table 3 , panels 1 and 2. Examination of the haplotype and single SNP frequencies showed some significant differences for a number of markers between popula- Figure 3 Single SNP association analysis in 464 individuals of the initial set of 116 AGRE families using TDTPhase. Initially, 113 SNPs were genotyped to cover the entire 4 Mb linkage interval (black dots). Several SNPs within the OTOA and PRKCB1 gene showed nominal evidence for association in the single SNP analysis. The SNP density was, therefore, increased in these two genes (OTOA, pink dots and PRKCB1, red dots, respectively) to achieve an average density of 2.5 kb. Figure 4 Haplotype heat-map of the PRKCB gene region. The map was established using the entire study population. Population-specific heat-maps for the Caucasian and Mexican-American populations are available as Supplementary material. Pairwise LD among SNPs was investigated using the Haploview software. 40 The figure depicts the standard color scheme heat-map: white for D 0 o1 and LODo2, blue for D 0 ¼ 1 and LODo2, shades of pink/red when D 0 o1 and LODZ2, bright red for D 0 ¼ 1 and LODZ2. Haplotype blocks were determined by identifying the first and last markers in a block, which are in strong LD with all intermediate markers. The schema above the map depicts the PRKCB1 gene structure relative to the LD map and SNPs that were genotyped. tions 1 and 2 (data not shown). Both populations were obtained from the AGRE repository and include samples from different ethnic groups. In order to adjust for any population stratification effects, we therefore repeated the haplotype analysis for each ethnic group separately. For about 30% of the samples, no ethnic information was available in both sets and they were excluded from the analysis. Haplotype analysis in Caucasians only confirmed the association of haplotype C-G-T (SNPs 139-140-141) in set 1 and showed positive replication for this haplotype in set 2. The results for the stratified analysis are shown in Table 3 , panels 3-5. The combined analysis of sets 1 and 2 yielded significant evidence for association of this haplotype at P ¼ 9.09 Â 10
À6
. Owing to the small sample number, only combined analysis of sets 1 and 2 were carried out in Mexican-Americans. A significant positive Pvalue was observed for haplotype G-C-G (SNPs 183, 184, 185 P ¼ 2.9 Â 10
À4
). Figure 5 shows the genomic organization of the PRKCB1 gene and the position of the positive haplotypes from the pooled Caucasian and Mexican-American samples, respectively. The sample sizes for the remaining ethnic groups were too small for meaningful haplotype analysis.
Discussion
Using a direct, high-density IBD mapping method, we performed a genome-wide linkage scan in 116 families from the AGRE DNA repository. We focused on a narrow phenotype definition for autism associated with speech delay beyond 36 months of age. We identified seven loci with evidence for linkage with autism. Four of these genomic regions on chromosomes 5, 13, 16 and 17 have been described previously in microsatellite-based linkage studies. [19] [20] [21] 23, 25, 28 Our genome scan adds further evidence to the involvement of these loci in autism. We were able to limit the search for the susceptibility genes to relatively small regions because of the high density that can be achieved using the direct IBD mapping method (0.85 Mb in our study). That higher density mapping can increase the information content and decrease the spread of the linkage interval has 
Markers in bold delineate SNPs selected for the first pass association study. Markers in italics are added gene specific markers. 
À6
The analysis shows replication of the association for haplotype C-G-T (SNPs 130-140, 141) in the Caucasian population.
PRKCB1 gene association with autism A Philippi et al recently also been reported for linkage scans using high-density SNP chips with a genome-wide coverage comparable to our study. [43] [44] [45] Direct IBD mapping methods using mismatch repair enzymes have been proposed by several authors. 35, 36, 46, 47 Mirzayans et al 48 applied this method to identify the human chromosomal region containing the iridogoiodysgenesis locus. To our knowledge, our current study is the first time this approach has been used to map loci in a complex disease in sib-pairs. The high concordance of our results with loci published in other autism genome-wide scans using traditional linkage mapping methods and the independent confirmation of the linkage results using high-density SNP genotyping in our own sample show that this method can be successfully applied to identify disease loci in complex diseases. The focus on narrower phenotypes to facilitate the identification of disease loci has been proposed by several researchers. In autism, speech delay has been a criteria of particular interest to stratify family samples towards a more severe phenotype and presumably a higher genetic load. 24, 29, 49 Speech delay was shown to be strongly familial and could therefore be considered an indication for an increased genetic effect for this particular phenotype. 33 Our genome scan confirms linkage of a region on chromosome 16p13.1-16p11.2 with autism. This chromosomal region was reported as being linked to autism in two earlier independent microsatellite studies. 23, 25 Although, several other genome-wide studies did show no or only weak evidence for linkage to this region, 20, 21, 27 this is to be expected in a complex disease situation. Two genome-wide studies, Liu et al 23 and Yonan et al, 27 used families from the AGRE collection also used in our study. Whereas the first reported linkage to chromosome 16p, the second did not replicate the linkage in this region. However, both studies included a much broader phenotype definition than our study. The respective overlap of AGRE samples between our study and those two earlier studies were 48% with Liu et al and 31% with Yonan et al, respectively. This may to some extent explain the higher concordance of our results with the Liu et al report and also account for some of the differences between all three studies. It is interesting to note that a particular duplication of this chromosomal region has also been reported associated with autism and Tourette's syndrome. 50 The linkage region identified in our scan spreads over approximately 4.5 Mb and harbors 41 known genes. Rather than applying a positional candidate gene approach, we decided to perform a high-density SNP-based association approach covering the whole region. We initially selected 113 SNPs covering the region at an average density of 39 kb. Transmission disequilibrium tests using two programs (Genehunter and TDT_Phase) as well as a pedigree-based method (PDT_Phase) were used to analyze the genotyping results. We found initial significant evidence for association with SNPs anchored in two distinct regions about 3 Mb apart. The associated SNPs were intragenic for the PRKCB1 gene and the gene coding for otoancorin (OTOA), respectively. However, subsequent genotyping of additional SNPs in both genes showed no further evidence for association of the OTOA gene, whereas the positive results in the PRKCB1 gene were supported by the additional SNPs. Haplotype analysis of the SNPs show consistent evidence for association for a number of three marker haplotypes within the gene. The most significant result was observed for the C-G-T haplotype of SNPs 139, 140 and 141. Sequencing of the coding region of the PRKCB1 gene did not reveal any amino-acid exchanges (data not shown) or other obvious function mutations (eg splice site mutations).
In order to confirm the association results, a second independent, larger set of 167 trio families was studied for the SNPs within the linkage region. Haplotype analysis confirmed association of haplotypes within the PRKCB1 gene with autism. However, the maximim P-value haplotype was shifted by several haplotype windows towards the 3 0 -end of the gene compared to the first family set. The comparison of the marker allele frequencies showed marked differences between the two sets. To test if these differences in the haplotype analysis results were not due to differences in population admixture, we repeated the analysis for each ethnic group separately. In Caucasians, the most significant result was again obtained for the C-G-T haplotype of SNPs 139, 140 and 141 not only in family set 1 but also in set 2. In Mexican-Americans, this particular haplotype was not significant, however a different haplo- 0 -end of the gene showed significant results. The C-G-T haplotype is located between the first two major haplotype blocks of the gene. In the Mexican-American subset, there is a marked decrease in LD in this particular region. The differences in the haplotype structures between the Caucasian and the Mexican-American population (an ethnic group with recent admixture) are not necessarily surprising. It seems unlikely that either of the haplotypes includes the causative polymorphisms. However, given the differences in the haplotype structure, it is not excluded that the actual causative polymorphism(s) or mutation(s) are the same in both groups.
The numbers for the other ethnic groups included in the sample were too small for meaningful analysis. Our results show the importance of taking the population structure into account when using haplotypes for association studies.
The PRKCB1 gene is mainly expressed in white blood cells and in the granule cells of the brain. Two distinct splice forms PRKCB1-1 and PRKCB1-2 exist. PRKCB1-2 is most predominantly found in the synaptic endings of the parallel fibers of the granule cells. 42 This isoform of the protein kinase C family plays a central role in the regulation of synaptic transmission. 51 The parallel fibers of the granule cells transfer afferent signals from deeper brain regions and the spine to the Purkinje cells. The dendrites of each Purkinje cell are in contact with parallel fibers from about 200 000 granule cells. Both decreased number of Purkinje and granule cells have been reported in brains from autistic individuals. [52] [53] [54] [55] Morrison and Mason 56 showed that granule neurons play a role in Purkinje cell development. They further showed that specific interactions between neurotrophins like BDNF and the glutaminergic synaptic system could lead to decreased Purkinje cell survival. Interestingly, it has been reported that specific activation of PRKCB1-2 enhances auditory reversal learning in rats. 57 Thus, one could speculate that deficiency in PRKCB1-2 might have the reverse effect and lead to impairment of such learning capacity. That the gene seems specifically involved in auditory learning might argue for an involvement in the marked delay in the onset of speech for which the autistic individuals included in this study were selected.
Our association with PRKCB1 is also interesting in respect of the complex genetics of autism. Some of the prime candidates for autism genes are functionally connected to PRKCB1. 51 In the context of linkage and association studies, two genes within this network are of special interest, the serotonin receptor gene (SLC6A4) and the neurofibromin 1 gene (NF1) both on chromosome 17q. Both genes have been implicated in autism. This particular region has shown evidence for linkage in several genome-wide studies. [58] [59] [60] Some association studies have also found significant evidence for association with the SLC6A4 gene although others have not been able to confirm those. 61 The NF1 gene lies within the same region but few studies have focused on this gene. 62, 63 In our genome-wide scan, we also found significant evidence for linkage with the region on chromosome 17q. The maximum IBD sharing was located closer to the NF1 than the SLC6A4 gene. SNP genotyping and association analysis in the region also supported an association of the NF1 gene rather than the SLC6A4 gene with autism (data not shown). Our finding may indicate the involvement of a common pathway in the etiology of certain forms of autism. The finding that functionally associated genes may be responsible for the genetic susceptibility to autism could also be helpful in guiding the strategy taken to identify further autism genes in the rather large linkage intervals from the various microsatellite scans. Indeed such an approach was recently proposed by Yonnan et al. 51 The limitations of this approach are our incomplete knowledge of the networks of interaction between the various genes that may be involved in autism.
A further intriguing aspect of the association with the PRKCB1 gene is its expression pattern in B lymphocytes. Alterations of the immune system have been reported in autism [64] [65] [66] [67] and interestingly also in Tourette's syndrome, 68 ,69 both of which have been associated with a duplication of the chromosomal region harboring the PRKCB1 gene as discussed above. Mice in which the PRKCB gene was disrupted showed an immunodeficiency. 70 In this context, it is noteworthy that Araki et al 71 recently reported a PRKCB1 association with diabetic nephropathy in type 1 diabetics, a clear autoimmune disease. These findings might link the PRKCB1 gene to both some of the learning inabilities and the immune alterations sometimes seen in autism. In this study, no information was available as to the immune status of the autistic cases. However, in autistic populations where these data are available, it would be interesting to evaluate a potential association of the haplotypes described here in respect to the immune status.
We also found some initial evidence for association in a second region of the linkage peak, encompassing the OTOA gene. Although the significance level for this second association is weaker and was not supported by genotyping further markers in the gene, there is the possibility that OTOA itself is indeed associated with autism. The OTOA gene is not expressed in the brain but solely in the inner ear at the interface between the apical surface and the inner ear sensory epithelia. 72 The gene was first cloned in 2002 and it was shown that a disruptive, recessive splice site mutation in the gene lead to deafness in a large Palestinian family. 72 Affected members of the family presented a moderate to severe prelingual deafness. It has been reported that in some cases with speech delay in autism, the individuals were also diagnosed with decreased hearing capacity comparable to a moderate deafness. However, our current data do not support that OTOA is a positional candidate for this chromosomal region.
Taken together, PRKCB1 exhibits a function in the brain and possibly in B-lymphocytes, the deregulation of which would be consistent with many of the PRKCB1 gene association with autism A Philippi et al symptoms seen in autism. Our association results show that haplotypes within the gene are strongly associated with autism and we were able to replicate a particular haplotype association in a second independent set of Caucasian families. Our data suggest that the PRKCB1 gene may be involved in the etiology of autism.
